Transaction · 0002010019-26-000002

Moshkevich Solomon

Moshkevich Solomon, PRES, reported an open-market or private sale at Natera, Inc. involving 1292.000000 shares for an estimated $295001.58. Reported holdings after the transaction were 125158.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SPRES
NTRANatera, Inc.
Filing timeJan 07
Trade dateJan 02, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

NTRA price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
NTRA since 2026-01-07Filed 240 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0002010019-26-000002
Common Stock
Transaction date
Jan 02, 2026
Filed Jan 07, 2026, 02:05 AM · 5d delay
Shares
1.29k sh
$22.8k per share
Estimated value
-$29.5M
Computed from shares × price
Holdings after
125k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

PRESIDENT, CLINICALDIAGNOSTICS

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024.

  2. F2

    The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.8050 to $228.76 per share, inclusive. The holder undertakes to p…

  3. F3

    The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.94 to $229.73 per share, inclusive. The holder undertakes to pro…

Original filing · 0002010019-26-000002
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

NTRA